Tarsus Pharmaceuticals, Inc.·4

Jun 29, 4:31 PM ET

YARNO WENDY L 4

4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 29, 2026

Research Summary

AI-generated summary of this filing

Updated

Tarsus (TARS) Director Wendy Yarno Receives Equity Awards

What Happened Wendy L. Yarno, a non-employee director of Tarsus Pharmaceuticals (TARS), was granted three equity awards on 2026-06-25: an option for 3,837 shares (grant price $0.00) and two restricted stock unit (RSU) awards for 2,417 and 1,209 shares (total RSUs = 3,626). The reported dollar price for each grant is $0.00 because these are compensatory awards, not open-market purchases or sales. Total shares subject to the awards = 7,463.

Key Details

  • Transaction date: 2026-06-25; Form 4 filed 2026-06-29 (filed within two business days, timely).
  • Reported price: $0.00 for all three entries (award/grant code A; derivative instruments).
  • Shares acquired: 3,837 (option), 2,417 RSUs, 1,209 RSUs — total 7,463.
  • Shares owned after transaction: Not specified in the provided filing details.
  • Relevant footnotes from the filing:
    • F1: 3,837-option is an annual option for non-employee directors; vests in full one year after grant, subject to continuous service.
    • F2: Each RSU represents a contingent right to one share of common stock.
    • F3: 2,417 RSUs vest in full one year after grant, subject to continuous service.
    • F4: 1,209 RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to continuous service.

Context These transactions are compensatory equity awards to a non-employee director, a common form of director compensation. RSUs and options are derivative awards that vest over time and do not represent immediate cash proceeds or open-market buying/selling. The filing appears timely under Form 4 rules (reported within two business days of the transaction).

Insider Transaction Report

Form 4
Period: 2026-06-25
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-06-25+3,8373,837 total
    Exercise: $64.34Exp: 2036-06-24Common Stock (3,837 underlying)
  • Award

    Restricted Stock Units

    [F2][F3]
    2026-06-25+2,4172,417 total
    Common Stock (2,417 underlying)
  • Award

    Restricted Stock Units

    [F2][F4]
    2026-06-25+1,2091,209 total
    Common Stock (1,209 underlying)
Footnotes (4)
  • [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
  • [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
  • [F3]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
  • [F4]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.
Signature
/s/ Scott Sieckert, Attorney-in-Fact|2026-06-29

Documents

1 file
  • 4
    wk-form4_1782765069.xmlPrimary

    FORM 4